ENGINEERING OF CELL-PENETRATING PEPTIDE-CONJUGATED INTRACELLULAR DELIVERY SYSTEMS - Biologically-Responsive Hybrid Biomaterials - page 224

[11] Morris, M.C., et al., “A new peptide vector for efficient delivery of oligonucleotides into
mammalian cells,” Nucleic Acids Res , Vol. 25, No. 14, 1997, pp. 2730-6.
[12] Futaki, S., et al., “Arginine-rich peptides. An abundant source of membrane-permeable
peptides having potential as carriers for intracellular protein delivery,” J Biol Chem , Vol.
276, No. 8, 2001, pp. 5836-40.
[13] Jeang, K.T., Xiao, H., and Rich, E.A., “Multifaceted activities of the HIV-1 transactivator
of transcription, Tat,” J Biol Chem , Vol. 274, No. 41, 1999, pp. 28837-40.
[14] Green, M., and Loewenstein, P.M., “Autonomous functional domains of chemically
synthesized human immunodeficiency virus tat trans-activator protein,” Cell , Vol. 55, No.
6, 1988, pp. 1179-88.
[15] Frankel, A.D., and Pabo, C.O., “Cellular uptake of the tat protein from human
immunodeficiency virus,” Cell , Vol. 55, No. 6, 1988, pp. 1189-93.
[16] Park, J., et al., “Mutational analysis of a human immunodeficiency virus type 1 Tat protein
transduction domain which is required for delivery of an exogenous protein into
mammalian cells,” J Gen Virol , Vol. 83, No. Pt 5, 2002, pp. 1173-81.
[17] Derossi, D., et al., “Cell internalization of the third helix of the Antennapedia homeodomain
is receptor-independent,” J Biol Chem , Vol. 271, No. 30, 1996, pp. 18188-93.
[18] Schwarze, S.R., and Dowdy, S.F., “In vivo protein transduction: intracellular delivery of
biologically active proteins, compounds and DNA,” Trends Pharmacol Sci , Vol. 21, No. 2,
2000, pp. 45-8.
[19] Lundberg, M., and Johansson, M., “Is VP22 nuclear homing an artifact?,” Nat Biotechnol ,
Vol. 19, No. 8, 2001, pp. 713-4.
[20] Pichon, C., Monsigny, M., and Roche, A.C., “Intracellular localization of oligonucleotides:
influence of fixative protocols,” Antisense Nucleic Acid Drug Dev , Vol. 9, No. 1, 1999, pp.
89-93.
[21] Richard, J.P., et al., “Cell-penetrating peptides. A reevaluation of the mechanism of cellular
uptake,” J Biol Chem , Vol. 278, No. 1, 2003, pp. 585-90.
[22] Console, S., et al., “Antennapedia and HIV transactivator of transcription (TAT) “protein
transduction domains” promote endocytosis of high molecular weight cargo upon binding
to cell surface glycosaminoglycans,” J Biol Chem , Vol. 278, No. 37, 2003, pp. 35109-14.
[23] Lundberg, M., Wikstrom, S., and Johansson, M., “Cell surface adherence and endocytosis
of protein transduction domains,” Mol Ther , Vol. 8, No. 1, 2003, pp. 143-50.
[24] Leifert, J.A., Harkins, S., and Whitton, J.L., “Full-length proteins attached to the HIV tat
protein transduction domain are neither transduced between cells, nor exhibit enhanced
immunogenicity,” Gene Ther , Vol. 9, No. 21, 2002, pp. 1422-8.
[25] Sandgren, S., Cheng, F., and Belting, M., “Nuclear targeting of macromolecular polyanions
by an HIV-Tat derived peptide. Role for cell-surface proteoglycans,” J Biol Chem , Vol.
277, No. 41, 2002, pp. 38877-83.
[26] Mai, J.C., et al., “Efficiency of protein transduction is cell type-dependent and is enhanced
by dextran sulfate,” J Biol Chem , Vol. 277, No. 33, 2002, pp. 30208-18.
[27] Violini, S., et al., “Evidence for a plasma membrane-mediated permeability barrier to Tat
basic domain in well-differentiated epithelial cells: lack of correlation with heparan
sulfate,” Biochemistry , Vol. 41, No. 42, 2002, pp. 12652-61.
[28] Rothbard, J.B., et al., “Role of membrane potential and hydrogen bonding in the mechanism
of translocation of guanidinium-rich peptides into cells,” J Am Chem Soc , Vol. 126, No. 31,
2004, pp. 9506-7.
[29] El-Andaloussi, S., et al., “A novel cell-penetrating peptide, M918, for efficient delivery of
proteins and peptide nucleic acids,” Mol Ther , Vol. 15, No. 10, 2007, pp. 1820-6.